Status:
COMPLETED
Alzheimer and Sleep
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
Janssen-Cilag Farmaceutica Ltda.
Conditions:
Alzheimer's Disease
Eligibility:
All Genders
65+ years
Phase:
PHASE1
Brief Summary
The aim of the study is the analysis of two inhibitors of Ach-E: galantamine and donépézil in over 65 years' old patients suffering from Alzheimer disease (MMSE between 20 and 26) without Alzheimer's ...
Detailed Description
Feasibility study, open, randomized, controlled, cross-over study in 65 years old patients.
Eligibility Criteria
Inclusion
- 65 and over years old
- Patients suffering from Alzheimer disease
- Patient living with someone at home
- Written consent given
Exclusion
- Galantamine or Donepezil hypersensibility
- Patient living alone and in a medicalized structure
- Concomitant medication
- Chronical diseases
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00750529
Start Date
November 1 2008
End Date
September 1 2013
Last Update
July 8 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63003
2
CPC-CIC
Clermont-Ferrand, France, 63003